Abnormal expression of MDM-2 in breast carcinomas

C E Bueso-Ramos1, T Manshouri, M A Haidar

  • 1Department of Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

Insights

MDM-2 oncoprotein is overexpressed in most breast cancers, affecting p53 function. This study found MDM-2 mRNA and protein alterations, particularly the p57 variant, in human breast carcinoma tissues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • MDM-2 is a cellular oncoprotein that inhibits the tumor suppressor p53.
  • MDM-2 alterations, including gene amplification and overexpression, are implicated in various cancers.
  • Specific MDM-2 protein isoforms like p57 are known to exist.

Purpose of the Study:

  • To investigate MDM-2 mRNA and protein expression in human breast carcinoma.
  • To determine if MDM-2 overexpression occurs independently of gene amplification in breast cancer.
  • To identify the predominant MDM-2 protein isoforms involved in breast carcinoma.

Main Methods:

  • Quantitative analysis of MDM-2 mRNA levels in breast carcinoma and normal tissues.
  • Western blot analysis to assess MDM-2 protein expression and isoforms.
  • Immunohistochemistry to confirm MDM-2 and p53 protein expression.
  • Analysis of MDM-2 gene amplification status.

Main Results:

  • MDM-2 mRNA overexpression was observed in 73% of breast carcinomas, without gene amplification.
  • A strong correlation was found between MDM-2 mRNA and protein overexpression.
  • MDM-2 protein overexpression, particularly the p57 isoform, was detected in 15 out of 21 breast carcinoma samples.

Conclusions:

  • MDM-2 oncoprotein expression is significantly altered at both mRNA and protein levels in primary human breast carcinomas.
  • MDM-2 overexpression in breast cancer occurs independently of gene amplification.
  • The MDM-2 p57 protein isoform appears to be the primary altered form in breast carcinomas, suggesting its potential role in tumorigenesis.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...